MS, Z., R, G., DJ, A., CL, S., VY, C., & S, M. (2026). Elevated serum creatinine over the first week of life and mortality risk in extremely preterm neonates: A secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT). Pediatric nephrology (Berlin, Germany). https://doi.org/10.1007/s00467-026-07294-7
Chicago Style (17th ed.) CitationMS, Zhou, Griffin R, Askenazi DJ, Slagle CL, Chock VY, and Menon S. "Elevated Serum Creatinine over the First Week of Life and Mortality Risk in Extremely Preterm Neonates: A Secondary Analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT)." Pediatric Nephrology (Berlin, Germany) 2026. https://doi.org/10.1007/s00467-026-07294-7.
MLA (9th ed.) CitationMS, Zhou, et al. "Elevated Serum Creatinine over the First Week of Life and Mortality Risk in Extremely Preterm Neonates: A Secondary Analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT)." Pediatric Nephrology (Berlin, Germany), 2026, https://doi.org/10.1007/s00467-026-07294-7.